Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876

Key Points

• This research aims to investigate the effects of GSK2830371 on WIP1 inhibition and subsequent p53 activation in liver cancer cells.
• Inhibition of WIP1 using GSK2830371
• Analysis of p53 phosphorylation levels
• Examination of cellular responses in liver adenocarcinoma cells
• Increased p53 phosphorylation observed with GSK2830371 treatment
• Enhanced activation of p53 leads to improved cellular response in liver cancer cells
• Potential augmentation of cancer therapeutic strategies noted